Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Hydroxyurea + NU6027 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Hydroxyurea | Droxia | Carbamohydroxamic Acid|Hydroxycarbamide | Droxia (hydroxyurea) inhibits ribonucleoside diphosphate reductase, resulting in cell cycle arrest (NCI Drug Dictionary). | |
NU6027 | ATR Inhibitor 16 CDK2 Inhibitor 31 | NU6027 is a small molecule inhibitor of ATR and CDK2, which may enhance the sensitivity of chemotherapeutic agents and result in decreased cell survival (PMID: 21730979, PMID: 27355194). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|